Clinical Trials Directory

Trials / Completed

CompletedNCT02461472

Risk Analysis for Diabetic Cardiovascular Autonomic Neuropathy

The Risk Analysis for Diabetic Cardiovascular Autonomic Neuropathy in General Chinese Population

Status
Completed
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine · Academic / Other
Sex
All
Age
30 Years – 90 Years
Healthy volunteers
Accepted

Summary

A large-scale, community-based, cross-sectional study was conducted to explore the extent to which risk factors associated with diabetic cardiovascular autonomic neuropathy (DCAN) in general Chinese population. A total of more than 2000 diabetic participants were recruited by using multiple stages sampling (first cluster sampling and then simply sampling). Data involved in demographic information, clinical biomarkers such as glucose and lipids profiles, medical and therapy history were collected. Every participants was complete DNA extracted and genotyped. Diabetic Cardiovascular autonomic functions were measured by using short-term heart rate variability (HRV) to evaluate the outcome of DCAN. Univariate and multiple variables analysis have been performed to examine potential environmental and genetic risk factors of CAN. In addition, clinical risk model, simply screening model and nonlinear system model such as artificial neural network was created, respectively.

Detailed description

Little is known about the risk factors and risk models for diabetic cardiovascular autonomic neuropathy in Chinese population. A large-scale, community-based, cross-sectional study was conducted to explore the extent to which risk factors associated with diabetic cardiovascular autonomic neuropathy (DCAN) in general Chinese population. A total of more than 2000 diabetic participants were recruited by using multiple stages sampling (first cluster sampling and then simply sampling). Data involved in demographic information, clinical biomarkers such as glucose and lipids profiles, medical and therapy history were collected. Every participants was complete DNA extracted and genotyped. Diabetic Cardiovascular autonomic functions were measured by using short-term heart rate variability (HRV) to evaluate the outcome of DCAN. Univariate and multiple variables analysis have been performed to examine potential environmental and genetic risk factors of CAN. In addition, clinical risk model, simply screening model and nonlinear system model such as artificial neural network was created, respectively.

Conditions

Interventions

TypeNameDescription
OTHERnot interventionThis is a cross-sectional study, no intervention was performed.

Timeline

Start date
2013-01-01
Primary completion
2018-08-01
Completion
2019-02-01
First posted
2015-06-03
Last updated
2019-03-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02461472. Inclusion in this directory is not an endorsement.